Navigation Links
Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data

ngle therapies could be effectively treated to this goal with Exforge, regardless of previous treatment.
In patients with type 2 diabetes in the same study, Exforge helped an impressive five out of 10 achieve a more aggressive treatment goal of reducing blood pressure to 130/80 mmHg.
"Most patients will require two or more medications to achieve optimal sustained blood pressure control," said Dr. Joseph Izzo, the lead investigator from the Department of Medicine at the State University of New York in Buffalo. "These data show that using Exforge in a real-life setting can get patients who were previously uncontrolled to a healthy blood pressure goal."
Following Swiss and European Union approval in early 2007, Exforge is currently available in Germany, Switzerland and the UK and is planned to be launched in the rest of the EU in 2007/2008. The US Food and Drug Administration (FDA) granted tentative approval for Exforge in December 2006, and this medicine is expected to become available in the US later in 2007 following the expiration of market exclusivity for Norvasc®* (amlodipine).
"Exforge is a very exciting addition to our cardiovascular portfolio," said Dr. James Shannon, Global Head of Development at Novartis Pharma AG. "The fact that nearly 70% of people with high blood pressure still do not have this potentially fatal condition under control demonstrates the need for powerful and more effective therapies."
High blood pressure and its consequences is the world's No. 1 cause of death[5]. This condition, also called hypertension, is when the blood in the body moves through the blood vessels at a higher pressure than normal and causes damage to the arteries, kidneys, brain and ot
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. ApoCells Cancer Predictive Index Helps Oncologists Select the Most Effective Targeted Drug Therapy
2. Study Suggests Invega Helps Patients With Schizophrenia Maintain Symptom Control
3. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
4. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
5. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
6. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
7. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
8. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
9. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
10. TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials
11. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
Post Your Comments:
(Date:7/28/2014)... Concord Medical Services Holdings Limited ("Concord Medical" or the ... hospital management solution provider and operator of the largest ... China , today announced that on July ... cash dividend of US$0.30 per ordinary share (or US$0.90 ... ordinary shares. The total expense for the special dividend ...
(Date:7/28/2014)... CHAPEL HILL, N.C. , July 28, 2014 /PRNewswire/ ... results of a clinical trial demonstrating that CXL-1427, a ... was well tolerated in healthy volunteers. The company has ... failure in a Phase IIa clinical trial designed to ... as its dosing levels. The Phase I ...
(Date:7/28/2014)... 2014  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ... Financial Results and Highlights Conference CallWhen:Monday, August 4 at ... How:Live on the Internet. Simply log onto our website ... the live event, a replay of the webcast will ... . ABOUT ISIS PHARMACEUTICALS, INC. Isis is ...
Breaking Medicine Technology:Concord Medical Declares Special Dividend 2Cardioxyl Pharmaceuticals Successfully Completes First Clinical Trial For Heart Failure Drug CXL-1427 2Webcast Alert: Isis Pharmaceuticals' Second Quarter 2014 Financial Results Conference Call 2
... allergic,asthma attacks and further define Xolair safety profile in ... up to their 12th birthday, - Xolair is ... associated,with approximately 78% of childhood asthma, - Allergic ... the age,of 18, - Xolair is currently approved ...
... SPEX ) reported that patient recruitment for its ... drug, Naturlose(R), has begun in,India. Expectations for India are ... for the pivotal Phase 3 trial. "Now that enrollment ... 3 trial will be completed,on schedule as reported during ...
Cached Medicine Technology:Study Shows Potential Benefits of Xolair(R) in Treating Children Suffering from Moderate or Severe Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids 2Study Shows Potential Benefits of Xolair(R) in Treating Children Suffering from Moderate or Severe Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids 3Study Shows Potential Benefits of Xolair(R) in Treating Children Suffering from Moderate or Severe Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids 4Study Shows Potential Benefits of Xolair(R) in Treating Children Suffering from Moderate or Severe Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids 5Study Shows Potential Benefits of Xolair(R) in Treating Children Suffering from Moderate or Severe Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids 6Study Shows Potential Benefits of Xolair(R) in Treating Children Suffering from Moderate or Severe Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids 7Patient Recruitment Begins in India for Phase 3 Diabetes Trial 2
(Date:7/28/2014)... 28, 2014 Glutamine is the most ... considered to be conditionally essential during times when the ... advanced recovery & Immune System Support. , Having a ... body produces, supplementing with additional glutamine may be advantageous. ... in the body, digestion and immune system function. Stress ...
(Date:7/28/2014)... By Maureen Salamon ... (HealthDay News) -- Infants and children who are at ... should be vaccinated against the infection, according to updated ... States. And routine vaccinations for the potentially ... the American Academy of Pediatrics says. In its ...
(Date:7/28/2014)... Endurance runners are far more likely to die of ... a new study. The researchers pointed out ... are actually 10 times more likely to develop severe ... death of a young and apparently healthy person due ... often gets a lot more media attention. "This ...
(Date:7/28/2014)... 28, 2014 SIMpalm helped its ... App is available on iTunes for download . Experience ... Audio Chef allows you to listen and cook along with ... way: simply get out the ingredients and equipment, press play, ... or prepare ingredients ahead of time, just relax and cook ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 The ... that has donated more than 200,000 books to children ... announces the launch of Brooke’s Cooks, a new initiative ... encouraging healthy living among at-risk children and their families ... include a series of nutrition information workshops, cooking demonstrations ...
Breaking Medicine News(10 mins):Health News:Betancourt Nutrition Introduces Glutamine Plus with Sustamine® L-Alanyl-L-Glutamine 2Health News:Betancourt Nutrition Introduces Glutamine Plus with Sustamine® L-Alanyl-L-Glutamine 3Health News:Doctors Urge Meningitis Shots for Vulnerable Infants, Children 2Health News:Doctors Urge Meningitis Shots for Vulnerable Infants, Children 3Health News:Heat Stroke a Greater Threat to Endurance Runners Than Heart Problems: Study 2Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 2Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 3Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 4Health News:Brooke Jackman Foundation Launches Brooke's Cooks, New Initiative to Promote Healthy Living Among At-Risk Youth and Their Families 2Health News:Brooke Jackman Foundation Launches Brooke's Cooks, New Initiative to Promote Healthy Living Among At-Risk Youth and Their Families 3Health News:Brooke Jackman Foundation Launches Brooke's Cooks, New Initiative to Promote Healthy Living Among At-Risk Youth and Their Families 4
... women receiving the same breast cancer treatments as Hispanic ... lower survival rates, were more likely to be diagnosed// ... to a study. ,For the study, ... M. D. Anderson Cancer Center and colleagues examined 2,140 ...
... According to a recent analysis by Metropolitan Transportation Authority, ... excessive dieting are among the top// causes, after the ... US subway. ,Asim Nelson, a transit ... statistics, taken between October 2005 and October 2006, shows ...
... among states and union territories to enforce screening of all ... disorder// that could lead to disabilities. ,Chandigarh ... children would be done to check any adverse fallout later. ... ,While poor people would be provided the facility ...
... giant-Coco Cola and Nestle have come together to manufacture a ... tea, caffeine and plant micronutrients. This is expected to hit ... consumers shed excess weight. ,According the chief scientist ... calories burnt. The soft drink company claims that detailed studies ...
... proposal released by Gov. Arnold Schwarzenegger recently, workers in ... benefit - to their// health and wealth. Employees will ... exempted from tax. ,The proposal is an ... reachable to the approximate 6.5 million Californians who are ...
... make you diabetic, says a study that tracked hospitalisation rates ... ,Type-two diabetes has seen a two-fold increase - from ... While scientists scramble to find explanations for the rise, experts ... , ,However, the study by Lawrence Lessner and colleagues ...
Cached Medicine News:Health News:Living Near Toxic Waste May Bring On Diabetes 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: